slotkoers
Andere beurzen
|
||
- USD | - |
|
15/05 | Transcript : Aspira Women's Health Inc., Q1 2024 Earnings Call, May 15, 2024 | |
15/05 | Aspira Women's Health Inc. rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024 | CI |
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Bio-analytic and Diagnostic Services
100,0
%
| 8 | 100,0 % | 9 | 100,0 % | +11,85% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 8 | 100,0 % | 9 | 100,0 % | +11,85% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Nicole Sandford
CEO | Chief Executive Officer | 54 | 22-02-21 |
Sandra Milligan
PSD | President | 60 | 01/04 |
Chief Operating Officer | - | - | |
Chief Tech/Sci/R&D Officer | - | 01-10-18 | |
Michelle Snider
PRN | Corporate Officer/Principal | - | 28-08-23 |
Diane Powis
PRN | Corporate Officer/Principal | - | 01-11-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ellen Vos
BRD | Director/Board Member | 68 | 09-05-23 |
Director/Board Member | 58 | 09-05-23 | |
Jannie Herchuk
CHM | Chairman | 61 | 09-05-23 |
Winfred Parnell
BRD | Director/Board Member | 71 | 01-06-23 |
Nicole Sandford
CEO | Chief Executive Officer | 54 | 22-02-21 |
Celeste Fralick
BRD | Director/Board Member | 68 | 23-02-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 12 449 512 | 7 619 753 ( 61,21 %) | 0 | 61,21 % |
Bedrijfsgegevens
Aspira Women's Health, Inc.
12117 Bee Caves Road Suite 100
78738, Austin
+512 519 0400
http://www.vermillion.com![Adres VERMILLION INC](https://cdn.zonebourse.com/static/address/9276458.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-34,58% | 8,68 mld. | |
+23,40% | 3,86 mld. | |
+12,55% | 2,43 mld. | |
-26,46% | 1,84 mld. | |
-10,65% | 1,73 mld. | |
+36,98% | 1,16 mld. | |
+51,46% | 842 mln. | |
-9,17% | 702 mln. | |
-10,71% | 594 mln. |